Chris Hollowood

Director/Board Member at APPLIED GENETIC TECHNOLOGIES CORPORATION

52 year

Health Technology

Finance

Miscellaneous

Profile

Dr. Christopher J.
Hollowood is a Chairman at Forcefield Therapeutics Ltd. and a Chief Executive Officer & Chief Investment Officer at Syncona Partners LLP.
He is on the Board of Directors at Beacon Therapeutics (USA), Inc., Spur Therapeutics Ltd. and Syncona Ip Holdco Ltd. Dr. Hollowood was previously employed as a Chairman by Purespring Therapeutics Ltd., a Chairman by SwanBio Therapeutics, Inc., a Chairman by Gyroscope Therapeutics Holdings Plc, a Chairman by Gyroscope Therapeutics Ltd., a Chairman by Freeline Therapeutics Holdings Ltd., a Chairman by Nightstar Therapeutics Plc, a Partner by Apposite Capital LLP, and a Chief Investment Officer by Syncona Ltd. He also served on the board at Convergence Pharmaceuticals Ltd., Bird Rock Bio Sub, Inc., Calchan Holdings Ltd. and NightstaRx Ltd. He received his doctorate degree from the University of Cambridge.

Chris Hollowood active positions

Companies	Position	Start
APPLIED GENETIC TECHNOLOGIES CORPORATION	Director/Board Member	01/12/2022
Forcefield Therapeutics Ltd. Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes	Chairman	01/11/2020
Syncona Ip Holdco Ltd.	Director/Board Member	-
Freeline Therapeutics Ltd. Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders	Founder	01/01/2015
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Chief Executive Officer	01/01/2023

All active positions of Chris Hollowood

Former positions of Chris Hollowood

Companies	Position	End
SwanBio Therapeutics, Inc. SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders	Chairman	16/10/2023
GYROSCOPE THERAPEUTICS HOLDINGS PLC	Chairman	17/02/2022
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases	Chairman	02/02/2022
NIGHTSTAR THERAPEUTICS PLC	Chairman	07/06/2019
░░░░░░░░ ░░░░░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░

See the detail of Chris Hollowood's experience

Education of Chris Hollowood

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Hollowood's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
Syncona Ltd. Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust	Miscellaneous
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services	Health Technology
Apposite Capital LLP Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-in and growth capital requirements. It also acquires minority interest.	Finance
Bird Rock Bio Sub, Inc. Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company	Health Technology
Convergence Pharmaceuticals Ltd. Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products	Health Technology
Calchan Holdings Ltd. Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain	Health Technology
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
NightstaRx Ltd. NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies	Health Services
Freeline Therapeutics Ltd. Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders	Health Technology
Nightstar Therapeutics Ltd. Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases	Health Technology
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases	Health Technology
SwanBio Therapeutics, Inc. SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders	Health Technology
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures next-generation gene therapies	Health Technology
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Health Technology
Gyroscope Therapeutics Holdings Plc Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes	Health Technology
Forcefield Therapeutics Ltd. Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes	Health Technology
Syncona Ip Holdco Ltd.